Table 1.
MiRNA | Circulation level | Liver expression | Function* | Identified targets |
---|---|---|---|---|
miR-21 | ↑10,11 | ↑9,15 | ↑ | FOXA2, FOXO1, HNF4α, STAT3, INSIG2,12 LRP6,13 Hbp1,15 PPARα16,17 |
miR-122 | ↑22,38 | ↑22↓23 | ↓25,28↑27 | Agpat1, Dgat1,25 CPEB1,28 Sirt129 |
miR-34a | ↑10,11 | ↑32,30 | ↑ | Sirt1,30,31,36 HNF4α,32 PPARα30 |
miR-27a | ↓39 | ↑40 | ↓40↑41 | FAS, SCD1,40 Nrf241 |
miR-29a | ↓42 | ↓43in fibrosis | ↓ | HMGCR,44 DNMT3b,45 CD36,43 GSK3β46 |
miR-132 | unknown | ↑47 | ↑ | FoxO3, PTEN, Sirt1, CYP2E1, P30047 |
miR-125b | ↑22 | ↑48 | ↓ | FAS49 |
miR-155 | unknown | ↑50,51 | ↓ | Ces3/TGH,50 LXα52 |
miR-192 | ↑11,22 | ↓53 | ↓ | SREBF1,54 SCD153 |
miR-378 | unknown | ↑55,56 | ↑ | Nrf156 |
* ↑: aggravating hepatic steatosis; ↓: alleviating hepatic steatosis.